BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27790140)

  • 1. The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of
    Guerrini F; Paolicchi M; Ghio F; Ciabatti E; Grassi S; Salehzadeh S; Ercolano G; Metelli MR; Del Re M; Iovino L; Petrini I; Carulli G; Cecconi N; Rousseau M; Cervetti G; Galimberti S
    Front Pharmacol; 2016; 7():363. PubMed ID: 27790140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
    Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
    Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
    Brown NA; Betz BL; Weigelin HC; Elenitoba-Johnson KS; Lim MS; Bailey NG
    Am J Clin Pathol; 2015 Jan; 143(1):89-99. PubMed ID: 25511147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
    Turakhia S; Lanigan C; Hamadeh F; Swerdlow SH; Tubbs RR; Cook JR
    Am J Clin Pathol; 2015 Jul; 144(1):87-93. PubMed ID: 26071465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.
    Arcaini L; Zibellini S; Boveri E; Riboni R; Rattotti S; Varettoni M; Guerrera ML; Lucioni M; Tenore A; Merli M; Rizzi S; Morello L; Cavalloni C; Da Vià MC; Paulli M; Cazzola M
    Blood; 2012 Jan; 119(1):188-91. PubMed ID: 22072557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association.
    Valvano L; D'Auria F; Grieco V; Statuto T; Nozza F; Pietrantuono G; Villani O; D'Arena G; Lamorte D
    Front Oncol; 2022; 12():1069977. PubMed ID: 36544707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.
    Brown NA; Weigelin HC; Bailey N; Laliberte J; Elenitoba-Johnson KS; Lim MS; Betz BL
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):590-600. PubMed ID: 24503706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia.
    Andrulis M; Penzel R; Weichert W; von Deimling A; Capper D
    Am J Surg Pathol; 2012 Dec; 36(12):1796-800. PubMed ID: 22531170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.
    Paillassa J; Maitre E; Belarbi Boudjerra N; Madani A; Benlakhal R; Matthes T; Van Den Neste E; Cailly L; Inchiappa L; Bekadja MA; Tomowiak C; Troussard X
    Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance.
    Robak T; Robak P
    Front Oncol; 2022; 12():976374. PubMed ID: 36439497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.
    Tiacci E; Schiavoni G; Forconi F; Santi A; Trentin L; Ambrosetti A; Cecchini D; Sozzi E; Francia di Celle P; Di Bello C; Pulsoni A; Foà R; Inghirami G; Falini B
    Blood; 2012 Jan; 119(1):192-5. PubMed ID: 22028477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
    Maitre E; Paillassa J; Troussard X
    Front Oncol; 2022; 12():1068981. PubMed ID: 36620555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic B-cell lymphoproliferative disorders with hairy cells].
    Troussard X; Cornet É
    Ann Biol Clin (Paris); 2015; 73(4):399-406. PubMed ID: 25858127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics of Hairy Cell Leukemia.
    Tiacci E; Pettirossi V; Schiavoni G; Falini B
    J Clin Oncol; 2017 Mar; 35(9):1002-1010. PubMed ID: 28297625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia.
    Arora N; Nair S; Pai R; Nair S; Ahmed R; Abraham A; Viswabandya A; George B; Balasubramanian P; Srivastava A; Mathews V
    Indian J Pathol Microbiol; 2015; 58(1):62-5. PubMed ID: 25673595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
    Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
    Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
    Broccoli A; Terragna C; Nanni L; Martello M; Armuzzi S; Agostinelli C; Morigi A; Casadei B; Pellegrini C; Stefoni V; Sabattini E; Argnani L; Zinzani PL
    Hematol Oncol; 2022 Feb; 40(1):57-62. PubMed ID: 34653277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders.
    Laurini JA; Aoun P; Iqbal J; Chan W; Greiner TC
    Am J Clin Pathol; 2012 Dec; 138(6):877-83. PubMed ID: 23161722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
    Assanto GM; Del Giudice I; Della Starza I; Soscia R; Cavalli M; Cola M; Bellomarino V; Di Trani M; Guarini A; Foà R
    Front Oncol; 2023; 13():1152467. PubMed ID: 36998457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.